According to DataHorizzon Research, The cell therapy market size was USD 4.9 Billion in 2022 and is projected to grow to USD 23.1 Billion by 2032 with a CAGR of 16.8%.
Fort Collins, Colorado, Sept. 25, 2023 (GLOBE NEWSWIRE) -- DataHorizzon Research Published a report titled, "Cell Therapy Market Size, Trends, Growth, Share, Statistics Analysis Report, By Cell Type, By End-user (Hospitals And Clinics, Research Institutes), By Therapy Type (Allogeneic And Autologous), By Region And Segment Forecasts, 2023-2032."
According to DataHorizzon Research, The cell therapy market size was USD 4.9 Billion in 2022 and is projected to grow to USD 23.1 Billion by 2032 with a CAGR of 16.8%. The global report offers a comprehensive market analysis and detailed insights at global and regional levels. The field of cell therapy is rapidly expanding, with new types of cells being introduced and more companies becoming involved. This presents an excellent opportunity for these organizations to establish themselves in the market. Over the past few years, there has been a surge in the number of companies working on cell therapies. This trend can be attributed to the growth in funding for clinical studies, the implementation of manufacturing guidelines, and the success of new products.
The medical biotechnology revolution has advanced with the emergence of cell therapy. This innovative therapy aims to replace unhealthy, damaged, or dysfunctional cells with healthy, active ones. Stem cells, which have the potential to differentiate into specific cells required for healing damaged or malfunctioning cells, are frequently used in cutting-edge therapies. Cell therapy is also a form of regenerative medicine, an interdisciplinary field that focuses on enhancing, preserving, or restoring tissue, cell, or organ function through various cell therapy-related techniques. Overall, cell therapy represents a promising avenue for improving health outcomes and promoting patient healing.
Furthermore, it is worth noting that the advancements in automation processes for adult stem cells and cord blood processing and storage are expected to significantly impact the growth of the adult and cord blood cells market. Moreover, key players in the market have initiated collaborative efforts to reprogram newborn stem cells extracted from umbilical cord blood and tissue into Induced Pluripotent Stem Cells (IPSCs), which is a critical development in this field.
The global cell therapy market has witnessed remarkable growth due to the adoption of innovative technologies that assist in developing sophisticated cellular therapies. Incorporating these new technologies has become crucial to the market's expansion. Companies leverage novel technologies to further enhance their product development plans by creating co-development agreements with other organizations and expanding their product offerings. This approach has proven effective in achieving business goals and meeting the market's needs.
Request Sample Report: https://datahorizzonresearch.com/request-sample-pdf/cell-therapy-market-2380
Cell Therapy Market
Market Size in 2022
USD 4.9 Billion
Market Size by 2032
USD 23.1 Billion
CAGR from 2023 to 2032
2023 to 2032
Report Scope & Coverage
Market Size, market estimations, competitor analysis, trends, and growth factors
By Cell Type
Stem Cell (blood, bone marrow, adipose-derived stem cell, umbilical cord-derived and others) and non-stem cell.
Hospitals, clinics, research institutes, and academics
By Therapy Type
Allogeneic and autologous
Europe, Latin America, North America, Asia Pacific, Middle East & Africa
UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Brazil, Mexico, Argentina, U.S., Canada, Saudi Arabia, South Africa, Japan, India, China, Australia, etc.
Major Market Players
Thermo Fisher Scientific Inc., Novartis AG, GlaxoSmithKline, Cells for Cells (C4C), JCR Pharmaceuticals Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc, Stemedica Cell technologies, Inc, Mesoblast Ltd, Medipost, and The Future of Biotechnology, NuVasive, and Vericel Corporation
The market for cell therapy has been divided into numerous segments based on factors like cell type, end-user, therapy type, and region. The stem cell section influences the global cell therapy market, as the government is pursuing initiatives to accelerate the growth of this segment. Additionally, it is observed that there is an increase in stem cell banks in various countries, which has accelerated the market growth. In the past few years, funding for stem cell research has increased significantly, such as it is funded by the federal government's National Institutes of Health (NIH) budget.
The research segment accounts for a significant global market share based on user type. Government policies are aiding in increased expenditures on the research and development sector, thereby driving growth in the overall cell therapy market. Conversely, clinical trials are expected to experience substantial growth in the upcoming years as cell therapy techniques are increasingly utilized to treat various disorders, thus accelerating segment growth.
North America's cell therapy market has grown significantly due to collaborations between research institutes and pharmaceutical companies, resulting in emerging advancements and increased awareness about chronic disorders. The region's healthcare development initiatives, government support, and academic research institutes' collaborative enterprises with the pharmaceutical sector have also contributed to market growth. The United States holds the largest market share due to its advanced healthcare system and research and disease diagnostics investments.
Buy This Research Report: https://datahorizzonresearch.com/checkout-page/cell-therapy-market-2380
Key Developments in the Cell Therapy Market:
Kolon Industries is investing 24 billion won ($18 million) to grow its petrochemical resin production factory in Yeosu, South Jeolla. This investment will increase the capacity of pure monomer resin from 11,000 to 21,000 tons annually. PMR is unquestionably renowned for its unparalleled thermal resistance and extreme durability, rendering it the unequivocal choice for various industrial applications, from high-performance tires to electric cables.
Stemedica Cell Technologies, a reputable manufacturer of allogeneic mesenchymal stem cells that are ischemic tolerant, has announced the initiation of its latest study. The study is a phase IIB/III, multicenter, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability, and efficacy of a single intravenous injection of allogeneic mesenchymal stem cells for individuals suffering from ischemic stroke. This study is being conducted under an existing US IND utilizing the company's itMSC product.
Cell Therapy Market Report Highlights:
The cell therapy market size is projected to grow to USD 23.1 Billion with a CAGR of 16.8% by 2032. Cell therapy is an emerging field with increasing funding and involvement from companies. In cutting-edge therapies, stem cells are frequently used to replace unhealthy or damaged cells. The advancements in automation processes for adult stem cells and cord blood processing and storage are expected to impact the market significantly. Collaborative efforts to reprogram newborn stem cells into iPSCs are also critical. Incorporating innovative technologies is crucial for expanding the market and meeting business goals.
The field of stem cell research has been expanding at a rapid pace owing to the rise in funding and various government initiatives. Stem cell banks have also played a significant role in contributing to the market's growth. The progress in research and clinical trials has been the key driver of the overall cell therapy market.
Collaborations between research institutes and pharmaceutical companies have led to significant growth in North America's cell therapy market. The United States holds the largest market share due to its advanced healthcare system and research investments.
Some prominent players in the global cell therapy market research report and analysis include Thermo Fisher Scientific Inc., Novartis AG, GlaxoSmithKline, Cells for Cells (C4C), JCR Pharmaceuticals Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc, Stemedica Cell Technologies, Inc, Mesoblast Ltd, Medipost, and The Future of Biotechnology, NuVasive, Vericel Corporation.
Looking Exclusively For Region/Country Specific Report?
Ask For Discount
Cell Therapy Market Report Segmentation:
Cell Therapy Market, By Cell Type (2023-2032)
Adipose-Derived Stem Cell
Cell Therapy Market, By End-user (2023-2032)
Hospitals & Clinics
Cell Therapy Market, By Therapy Type (2023-2032)
Cell Therapy Market, By Region (2023-2032)
Rest of Europe
Rest of Asia Pacific
Rest of Latin America
Middle East & Africa
Rest of Middle East and Africa
Major Players in the Cell Therapy Market
Thermo Fisher Scientific Inc.
Cells for Cells (C4C)
JCR Pharmaceuticals Co., Ltd.
Osiris Therapeutics, Inc.
Kolon TissueGene, Inc.
Stemedica Cell Technologies, Inc
The Future of Biotechnology
About DataHorizzon Research:
DataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics. Its offerings include consulting services across enterprises and business insights to make actionable decisions. DHR’s comprehensive research methodology for predicting long-term and sustainable trends in the market facilitates complex decisions for organizations.
Follow Us: LinkedIn
CONTACT: Mail: email@example.com Ph: +1-970-672-0390 Website: https://www.datahorizzonresearch.com